Sunpeaks Ventures – Symbol: SNPK -Our Hottest Pick EVER!

Sunpeaks Ventures, Inc (“Sunpeaks”), and wholly owned subsidiary Healthcare Distribution Specialists, LLC (“HDS”), is a nationally focused, value-added distributor of specialty drugs and over-the-counter (“OTC”) branded multivitamins to the healthcare provider market. According to the Healthcare Distribution Management Association, about 85% of all prescription medications are sold through healthcare distributors in the United States, which amounts to $248 billion in revenue. Currently, HDS serves the secondary segment of the specialty drug market, estimated by management to be a $30 billion market segment. HDS currently functions as a just-in-time source of supply for hospitals for those products that are hard-to-find due to drug manufacturers’ production shortages. In 2011 alone, there were over 200 drug shortages and by FDA estimates, this problem is only expected to worsen as more pharmaceuticals go generic. HDS is licensed in Alabama, Alaska, Arkansas, Colorado, Delaware, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Minnesota, Missouri, New Jersey, New Mexico, North Carolina, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, and Washington DC. HDS plans on being licensed to distribute pharmaceuticals in all 50 states. In addition to pharmaceuticals, HDS also distributes over-the-counter (“OTC”) branded health supplements which is approximately a $28 billion distribution market in the U.S. HDS is currently analyzing several OTC products that would allow us to become a powerful over-the-counter player in the multi-billon dollar health supplement market.
Sunpeaks Ventures Announces Improvement to Capital Structure and Reduction in Shares Outstanding [07-March-2012] SILVER SPRING, Md., March 7, 2012 /PRNewswire/ — Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the “Company” or “Sunpeaks Ventures”), value-added distributor of specialty drugs and over-the-counter (“OTC”) branded multivitamins to the healthcare provider market, is pleased to announce that it has forwarded all necessary documentation to the company’s transfer agent to cancel 50,000,000 common shares of the Company’s stock with the intent of improving the overall capital structure and to increase shareholder value. The cancelled shares were previously held by Mr. Mackie A. Barch, CEO of Sunpeaks. The share cancellation reduces the total number of issued and outstanding shares from 420,500,750 to 370,500,750. About Sunpeaks Ventures, Inc.
Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC (“HDS”), is a nationally focused, value-added distributor of specialty drugs and over-the-counter (“OTC”) branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.
For additional information, please visit www.sunpeaksventures.com. Contact: Financial Insights 888-248-8491 or info@sunpeaksventures.com Mackie Barch 202-270-5404
Safe Harbor Statement Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “forecast”, “anticipate”, “estimate”, “project”, “intend”, “expect”, “should”, “believe”, and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures’ actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures’ filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.